Clinical Trial Update: Treatment of Parkinson's Disease With Eliprodil [Phase 2]

View source ↗

Summary

This item reports a Phase 2 clinical trial evaluating eliprodil for Parkinson disease, sponsored by NINDS, with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Eliprodil

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Movement Disorders, Parkinson Disease | Phase 2 | Status: COMPLETED